Differences in Pediatric Headache Prescription Patterns by Diagnosis

Area of Science:

• Pediatric Neurology
• Pharmacology
• Clinical Trials

Background:

• Limited research exists on headache medication prescription patterns in pediatric populations.
• Understanding current prescribing practices is crucial for improving headache management in children and adolescents.

Purpose of the Study:

• To analyze prescription rates for pediatric migraine, tension-type headache (TTH), and new daily persistent headache (NDPH).
• To investigate variations in prescription patterns based on headache diagnosis, patient age, and gender.

Main Methods:

• Retrospective analysis of 14,591 pediatric patients (ages 4-17) diagnosed with migraine, TTH, or NDPH over three years.
• Data extracted using the i2b2 platform to identify prescribed medications and patient demographics.

Main Results:

• Sumatriptan and amitriptyline were the most common prescriptions for migraine. Amitriptyline was most frequent for TTH and NDPH.
• Prescription patterns differed significantly across diagnoses, age groups, and genders.
• A substantial proportion of prescribed headache medications were used off-label in this pediatric cohort.

Conclusions:

• Current pediatric headache treatment involves a broad spectrum of medications, often prescribed off-label.
• The lack of FDA-approved headache treatments for pediatric use necessitates further large-scale, randomized controlled trials.
• Evidence-based guidelines are needed to optimize the efficacy and safety of headache pharmacotherapy in children and adolescents.